There was no significant difference between the two study groups in the mean time to a cancer diagnosis ( 4.2 months in the limited-screening group and 4.0 months in the limited-screening-plus-CT group , P = 0.88 ) or in cancer-related mortality ( 1.4 % and 0.9 % , P = 0.75 ) .